首页> 外文期刊>Journal of enzyme inhibition and medicinal chemistry. >Synthesis and characterization of novel dioxoacridine sulfonamide derivatives as new carbonic anhydrase inhibitors
【24h】

Synthesis and characterization of novel dioxoacridine sulfonamide derivatives as new carbonic anhydrase inhibitors

机译:作为新型碳酸酐酶抑制剂的新型二氧杂cr啶磺酰胺衍生物的合成与表征

获取原文
       

摘要

Novel dioxoacridine sulfonamide compounds were synthesized from reaction of cyclic 1,3-diketones, sulfanilamide (4-amino benzene sulfonamide) and aromatic aldehydes. The structures of these compounds were confirmed by using spectral analysis (IR, H-NMR, 13C-NMR, and mass). Human carbonic anhydrase isoenzymes (hCA I and hCA II) were purified from erythrocyte cells by affinity chromatography. The inhibitory effects of sulfanilamide, acetazolamide (AAZ), and newly synthesized sulfonamides on hydratase and esterase activities of these isoenzymes have been studied in vitro. The IC50 values of compounds for esterase activity are 0.71–0.11 μM for hCA I and 0.45–0.12 μM for hCA II, respectively. The Ki values of these inhibitors were determined as 0,38–0,008 μM for hCA I and 0,19–0,001 μM for hCA II, respectively.
机译:由环状的1,3-二酮,磺胺(4-氨基苯磺酰胺)和芳香醛反应合成了新的二氧杂oa啶磺酰胺化合物。这些化合物的结构通过光谱分析(IR,1 H-NMR, 13 C-NMR和质量)确认。通过亲和色谱法从红细胞中纯化人碳酸酐酶同工酶(hCA I和hCA II)。在体外研究了磺胺,乙酰唑酰胺(AAZ)和新合成的磺酰胺对这些同工酶的水合酶和酯酶活性的抑制作用。化合物的酯酶活性的IC 50 值对于hCA I和hCA II分别为0.71-0.11μM和0.45-0.12μM。这些抑制剂的h i 的K i 值分别确定为hCA I为0.38-0.008μM和hCA II为0.19-0.001μM。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号